Ethylamine

Ethylamine

SCHEMBL127386

Br.Br.Br.Br.CCN.CCN.CCN.CCN

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Ethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 8/20 0.40
ALDH1A1 P00352 4/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
EPHX1 P07099 1/20 0.33
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylamine SCHEMBL28837477 1.00
Ethylamine SCHEMBL9536323 1.00
Ethylamine SCHEMBL9393995 1.00
Ethylamine SCHEMBL9393989 1.00
Ethylamine SCHEMBL9536330 1.00 DNM1 (0.40) DNM1ALDH1A1TSHRMEN1KMT2A
Ethylamine SCHEMBL473818 1.00
Ethylamine SCHEMBL23910301 0.94
Ethylamine SCHEMBL21751927 0.94
Ethylamine SCHEMBL1331327 0.93
Ethylamine SCHEMBL854887 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575293-B2 Resin composition for optical material and optical material using the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-11-05 US disclosed
EP-2058346-B1 RESIN COMPOSITION FOR OPTICAL MATERIAL AND OPTICAL MATERIAL USING THE SAME MITSUBISHI GAS CHEMICAL CO (JP) 2012-03-07 EP disclosed
US-20110218363-A1 METHOD FOR PRODUCING ALKENYL MERCAPTAN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-08 US disclosed
US-20100004421-A1 RESIN COMPOSITION FOR OPTICAL MATERIAL AND OPTICAL MATERIAL USING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2010-01-07 US disclosed
EP-2058346-A1 RESIN COMPOSITION FOR OPTICAL MATERIAL AND OPTICAL MATERIAL USING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2009-05-13 EP disclosed
EP-0614876-B1 Method of producing aromatic carbonate MITSUBISHI CHEM CORP (JP) 1997-04-09 EP disclosed
EP-0736512-A1 Method of producing aromatic carbonate Mitsubishi Chemical Corporation (JP) 1996-10-09 EP disclosed
US-5543547-A REACTION OF AROMATIC HYDROXY COMPOUND, CARBON MONOXIDE, AND OXYGEN CATALYZED WITH PALLADIUM COMPOUND, CERIUM COMPOUND, QUATERNARY AMMONIUM OR PHOSPHONIUM SALT, AND A QUINONE DERIVATIVE MITSUBISHI CHEMICAL CORPORATION (JP) 1996-08-06 US disclosed
EP-0614876-A1 Method of producing aromatic carbonate MITSUBISHI CHEMICAL CORPORATION (JP) 1994-09-14 EP disclosed
EP-0077542-B1 PROCESS FOR PREPARING DIESTERS OF MALONIC ACID UBE INDUSTRIES, LTD. (JP) 1985-09-18 EP disclosed
US-4539423-A FROM KETENE CARBON MONOXIDE AND ESTER OF NITROUS ACID; PLATINUM GROUP CATALYST UBE INDUSTRIES LTD. (JP) 1985-09-03 US disclosed
EP-0077542-A1 Process for preparing diesters of malonic acid UBE INDUSTRIES, LTD. (JP) 1983-04-27 EP disclosed
US-4147699-A β-Lactam precursors of penicillin and cephalosporin antibiotics MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1979-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218363-A1 METHOD FOR PRODUCING ALKENYL MERCAPTAN TST, MPST, HACL2 DNM1 4656/4885ALDH1A1 79/4885TSHR 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.